Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1701343
PUBLISHER: Grand View Research | PRODUCT CODE: 1701343
India Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Service, By Therapeutic Area, By End-use, And Segment Forecasts, 2025 - 2030
PUBLISHED:
PAGES: 90 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
India Pharmaceutical Contract Sales Organizations Market Growth & Trends:
The India pharmaceutical contract sales organizations market size is anticipated to reach USD 588.7 million by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.5% from 2025 to 2030. The growing pharmaceutical industry, pharmaceutical product approval, and commercialization are the major factors contributing to the market growth. As per the Indian Ministry of Health and Family Welfare, in 2022, the pharmaceutical sector in India comprised 3,000 drug companies and 10,500 manufacturing units.
The increasing outsourcing trends in the Indian pharmaceutical industry has propelled market expansion. Many companies use outsourcing research to India, appealing due to its advantages and benefits. The competitive pricing of services in India enables significant cost reduction for companies, providing them access to the market. A rising trend involves incorporating technology into outsourcing. Technological advancements like artificial intelligence, machine learning, and automation are reshaping the pharmaceutical industry, with CSOs leveraging these advancements to enhance their services.
Furthermore, strong government support and rising pharmaceutical R&D spending is expected to drive the market growth. For instance, in April 2023, the Indian government planned to enhance research and innovation in India's pharmaceuticals and medical technology sectors through a five-year program with a budget of USD 599.99 million. This development holds significance as research and development (R&D) constitute only 7% of the overall expenditure in the Indian pharmaceutical industry, in contrast to the over 35% observed in developed countries.
India Pharmaceutical Contract Sales Organizations Market Report Highlights:
- In terms of service, the non-personal promotion segment dominated the service segment with more than 56.0% share in 2024 owing to its efficiency and cost-effectiveness
- The personal promotion segment is also expected to show a significant share in the market. This is attributed to complex products and services
- In terms of end-use, the pharmaceutical companies segment held the largest market share in 2024. The increase in the number of new small molecule drug launches is anticipated to be a major driving factor for the market growth
- The biopharmaceutical companies' segment is expected to grow at the fastest CAGR over the forecast period
Product Code: GVR-4-68040-174-9
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Service
- 1.2.2. Therapeutic areas
- 1.2.3. End use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. India Pharmaceutical Contract Sales Organizations Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. India Pharmaceutical Contract Sales Organizations Market: Service Business Analysis
- 4.1. Service Market Share, 2024 & 2030
- 4.2. Service Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
- 4.4. Personal Promotion
- 4.4.1. Personal Promotion Market, 2018 - 2030 (USD Million)
- 4.4.2. Promotional Sales Team
- 4.4.2.1. Promotional Sales Team Market, 2018 - 2030 (USD Million)
- 4.4.3. Key Account Management
- 4.4.3.1. Key Account Management Market, 2018 - 2030 (USD Million)
- 4.4.4. Vacancy Management
- 4.4.4.1. Vacancy Management Market, 2018 - 2030 (USD Million)
- 4.5. Non-personal Promotion
- 4.5.1. Non-personal Promotion Market, 2018 - 2030 (USD Million)
- 4.5.2. Medical Affairs Solutions
- 4.5.2.1. Medical Affairs Solutions Market, 2018 - 2030 (USD Million)
- 4.5.3. Remote Medical Science Liaisons
- 4.5.3.1. Remote Medical Science Liaisons Market, 2018 - 2030 (USD Million)
- 4.5.4. Nurse Educators
- 4.5.4.1. Nurse Educators Market, 2018 - 2030 (USD Million)
- 4.5.5. Others
- 4.5.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. India Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Business Analysis
- 5.1. Therapeutic Areas Market Share, 2024 & 2030
- 5.2. Therapeutic Areas Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Areas, 2018 to 2030 (USD Million)
- 5.4. Oncology
- 5.4.1. Oncology Market, 2018 - 2030 (USD Million)
- 5.5. Cardiovascular
- 5.5.1. Cardiovascular Market, 2018 - 2030 (USD Million)
- 5.6. Neurology
- 5.6.1. Neurology Market, 2018 - 2030 (USD Million)
- 5.7. Infectious Diseases
- 5.7.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
- 5.8. Metabolic Disorders
- 5.8.1. Metabolic Disorders Market, 2018 - 2030 (USD Million)
- 5.9. Orthopedic Diseases
- 5.9.1. Orthopedic Diseases Market, 2018 - 2030 (USD Million)
- 5.10. Others
- 5.10.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. India Pharmaceutical Contract Sales Organizations Market: End Use Business Analysis
- 6.1. End Use Market Share, 2024 & 2030
- 6.2. End Use Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by End use, 2018 to 2030 (USD Million)
- 6.4. Pharmaceutical Companies
- 6.4.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
- 6.5. Biopharmaceutical Companies
- 6.5.1. Biopharmaceutical Companies Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Participant Overview
- 7.2. Company Market Position Analysis
- 7.3. Company Categorization
- 7.4. Strategy Mapping
- 7.5. Company Profiles/Listing
- 7.5.1. CMIC Holdings Co., Ltd.
- 7.5.1.1. Company Overview
- 7.5.1.2. Financial Performance
- 7.5.1.3. Product Benchmarking
- 7.5.1.4. Strategic Initiatives
- 7.5.2. Axxelus
- 7.5.2.1. Company Overview
- 7.5.2.2. Financial Performance
- 7.5.2.3. Product Benchmarking
- 7.5.2.4. Strategic Initiatives
- 7.5.3. EPS Corporation
- 7.5.3.1. Company Overview
- 7.5.3.2. Financial Performance
- 7.5.3.3. Product Benchmarking
- 7.5.3.4. Strategic Initiatives
- 7.5.4. QFR Solutions
- 7.5.4.1. Company Overview
- 7.5.4.2. Financial Performance
- 7.5.4.3. Product Benchmarking
- 7.5.4.4. Strategic Initiatives
- 7.5.5. MaBico
- 7.5.5.1. Company Overview
- 7.5.5.2. Financial Performance
- 7.5.5.3. Product Benchmarking
- 7.5.5.4. Strategic Initiatives
- 7.5.6. Mednext Pharma Pvt. Ltd.
- 7.5.6.1. Company Overview
- 7.5.6.2. Financial Performance
- 7.5.6.3. Product Benchmarking
- 7.5.6.4. Strategic Initiatives
- 7.5.7. Peak Pharma Solutions Inc.
- 7.5.7.1. Company Overview
- 7.5.7.2. Financial Performance
- 7.5.7.3. Product Benchmarking
- 7.5.7.4. Strategic Initiatives
- 7.5.8. IQVIA Inc.
- 7.5.8.1. Company Overview
- 7.5.8.2. Financial Performance
- 7.5.8.3. Product Benchmarking
- 7.5.8.4. Strategic Initiatives
- 7.5.9. Promoveo Health
- 7.5.9.1. Company Overview
- 7.5.9.2. Financial Performance
- 7.5.9.3. Product Benchmarking
- 7.5.9.4. Strategic Initiatives
- 7.5.10. Syneous Health
- 7.5.10.1. Company Overview
- 7.5.10.2. Financial Performance
- 7.5.10.3. Product Benchmarking
- 7.5.10.4. Strategic Initiatives
- 7.5.1. CMIC Holdings Co., Ltd.
Product Code: GVR-4-68040-174-9
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 India pharmaceutical contract sales organizations market, by service, 2018 - 2030 (USD Million)
- Table 4 India pharmaceutical contract sales organizations market, by therapeutic areas, 2018 - 2030 (USD Million)
- Table 5 India pharmaceutical contract sales organizations market, by end use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 India pharmaceutical contract sales organizations market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation services
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 Market formulation & validation
- Fig. 8 Market snapshot
- Fig. 9 Service, therapeutic areas and end use outlook (USD Million)
- Fig. 10 Competitive landscape
- Fig. 11 India pharmaceutical contract sales organizations market dynamics
- Fig. 12 India pharmaceutical contract sales organizations market: Porter's five forces analysis
- Fig. 13 India pharmaceutical contract sales organizations market: PESTLE analysis
- Fig. 14 India pharmaceutical contract sales organizations market: Service segment dashboard
- Fig. 15 India pharmaceutical contract sales organizations market: Service market share analysis, 2024 & 2030
- Fig. 16 Personal promotion market, 2018 - 2030 (USD Million)
- Fig. 17 Promotional sales team market, 2018 - 2030 (USD Million)
- Fig. 18 Key account management market, 2018 - 2030 (USD Million)
- Fig. 19 Vacancy management market, 2018 - 2030 (USD Million)
- Fig. 20 Non-personal promotion market, 2018 - 2030 (USD Million)
- Fig. 21 Medical affairs solutions market, 2018 - 2030 (USD Million)
- Fig. 22 Remote medical science liaisons market, 2018 - 2030 (USD Million)
- Fig. 23 Nurse educators market, 2018 - 2030 (USD Million)
- Fig. 24 Others market, 2018 - 2030 (USD Million)
- Fig. 25 India pharmaceutical contract sales organizations market: Therapeutic areas segment dashboard
- Fig. 26 India pharmaceutical contract sales organizations market: Therapeutic areas market share analysis, 2024 & 2030
- Fig. 27 Oncology market, 2018 - 2030 (USD Million)
- Fig. 28 Cardiovascular market, 2018 - 2030 (USD Million)
- Fig. 29 Neurology market, 2018 - 2030 (USD Million)
- Fig. 30 Infectious diseases market, 2018 - 2030 (USD Million)
- Fig. 31 Metabolic disorders market, 2018 - 2030 (USD Million)
- Fig. 32 Orthopedic diseases market, 2018 - 2030 (USD Million)
- Fig. 33 Others market, 2018 - 2030 (USD Million)
- Fig. 34 India pharmaceutical contract sales organizations market: End use segment dashboard
- Fig. 35 India pharmaceutical contract sales organizations market: End use market share analysis, 2024 & 2030
- Fig. 36 Pharmaceutical companies market, 2018 - 2030 (USD Million)
- Fig. 37 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
- Fig. 38 Company categorization
- Fig. 39 Company market position analysis
- Fig. 40 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.